Meeting Report
Melanoma: 2022 ASCO Annual Meeting Highlights for the Advanced Practitioner
Suzanne McGettigan, MSN, CRNP, AOCN®
J Adv Pract Oncol 2022;13(6):611-613 |
https://doi.org/10.6004/jadpro.2022.13.6.7 |
© 2022 Harborside™
ABSTRACT
Suzanne McGettigan, MSN, CRNP, AOCN®, of Abramson Cancer Center of the Hospital of the University of Pennsylvania, reviews data on adjuvant therapy in stage IIB or IIC melanoma and omitting lymph node dissection and adjuvant therapy in patients with resectable stage III melanoma with major pathologic response.
For access to the full length article, please
sign in.
